362 related articles for article (PubMed ID: 33636214)
1. Bile acids and their receptors in metabolic disorders.
Fiorucci S; Distrutti E; Carino A; Zampella A; Biagioli M
Prog Lipid Res; 2021 Apr; 82():101094. PubMed ID: 33636214
[TBL] [Abstract][Full Text] [Related]
2. Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders.
Fiorucci S; Sepe V; Biagioli M; Fiorillo B; Rapacciuolo P; Distrutti E; Zampella A
Biochem Pharmacol; 2023 Oct; 216():115776. PubMed ID: 37659739
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and Pharmacology of GPBAR1 and FXR Selective Agonists, Dual Agonists, and Antagonists.
De Marino S; Festa C; Sepe V; Zampella A
Handb Exp Pharmacol; 2019; 256():137-165. PubMed ID: 31201554
[TBL] [Abstract][Full Text] [Related]
4. The Pharmacology of Bile Acids and Their Receptors.
Fiorucci S; Distrutti E
Handb Exp Pharmacol; 2019; 256():3-18. PubMed ID: 31201555
[TBL] [Abstract][Full Text] [Related]
5. Bile Acid Signaling in Inflammatory Bowel Diseases.
Fiorucci S; Carino A; Baldoni M; Santucci L; Costanzi E; Graziosi L; Distrutti E; Biagioli M
Dig Dis Sci; 2021 Mar; 66(3):674-693. PubMed ID: 33289902
[TBL] [Abstract][Full Text] [Related]
6. Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH).
Fiorucci S; Biagioli M; Sepe V; Zampella A; Distrutti E
Expert Opin Investig Drugs; 2020 Jun; 29(6):623-632. PubMed ID: 32552182
[TBL] [Abstract][Full Text] [Related]
7. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease.
Marchianò S; Biagioli M; Bordoni M; Morretta E; Di Giorgio C; Vellecco V; Roselli R; Bellini R; Massa C; Cari L; Urbani G; Ricci P; Monti MC; Giordano A; Brancaleone V; Bucci M; Zampella A; Distrutti E; Cieri E; Cirino G; Fiorucci S
J Am Heart Assoc; 2023 Dec; 12(23):e031241. PubMed ID: 37996988
[TBL] [Abstract][Full Text] [Related]
8. Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity.
Sepe V; Renga B; Festa C; Finamore C; Masullo D; Carino A; Cipriani S; Distrutti E; Fiorucci S; Zampella A
Steroids; 2016 Jan; 105():59-67. PubMed ID: 26607331
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
[TBL] [Abstract][Full Text] [Related]
10. The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy.
Carino A; Marchianò S; Biagioli M; Scarpelli P; Bordoni M; Di Giorgio C; Roselli R; Fiorucci C; Monti MC; Distrutti E; Zampella A; Fiorucci S
FASEB J; 2021 Jan; 35(1):e21271. PubMed ID: 33368684
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation.
Carino A; Marchianò S; Biagioli M; Fiorucci C; Zampella A; Monti MC; Morretta E; Bordoni M; Di Giorgio C; Roselli R; Ricci P; Distrutti E; Fiorucci S
Nutrients; 2019 May; 11(5):. PubMed ID: 31117231
[TBL] [Abstract][Full Text] [Related]
12. Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands.
Finamore C; Festa C; Renga B; Sepe V; Carino A; Masullo D; Biagioli M; Marchianò S; Capolupo A; Monti MC; Fiorucci S; Zampella A
Sci Rep; 2016 Jul; 6():29320. PubMed ID: 27381677
[TBL] [Abstract][Full Text] [Related]
13. Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders.
Fiorucci S; Baldoni M; Ricci P; Zampella A; Distrutti E; Biagioli M
Curr Opin Pharmacol; 2020 Aug; 53():45-54. PubMed ID: 32480317
[TBL] [Abstract][Full Text] [Related]
14. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
Biagioli M; Carino A
Handb Exp Pharmacol; 2019; 256():95-108. PubMed ID: 31119464
[TBL] [Abstract][Full Text] [Related]
15. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators.
Fiorucci S; Zampella A; Cirino G; Bucci M; Distrutti E
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H21-H32. PubMed ID: 27765751
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Urbani G; Morretta E; Monti MC; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Nov; 1867(11):159218. PubMed ID: 35985473
[TBL] [Abstract][Full Text] [Related]
17. Bile Acids Activated Receptors in Inflammatory Bowel Disease.
Biagioli M; Marchianò S; Carino A; Di Giorgio C; Santucci L; Distrutti E; Fiorucci S
Cells; 2021 May; 10(6):. PubMed ID: 34064187
[TBL] [Abstract][Full Text] [Related]
18. Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1.
Di Leva FS; Festa C; Carino A; De Marino S; Marchianò S; Di Marino D; Finamore C; Monti MC; Zampella A; Fiorucci S; Limongelli V
Sci Rep; 2019 Feb; 9(1):2504. PubMed ID: 30792450
[TBL] [Abstract][Full Text] [Related]
19. FXR an emerging therapeutic target for the treatment of atherosclerosis.
Mencarelli A; Fiorucci S
J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
[TBL] [Abstract][Full Text] [Related]
20. Linking liver metabolic and vascular disease via bile acid signaling.
Fiorucci S; Distrutti E
Trends Mol Med; 2022 Jan; 28(1):51-66. PubMed ID: 34815180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
